search

Active clinical trials for "Syndrome"

Results 9711-9720 of 9759

Timing of Optimal Platelet Inhibition After Acute Coronary Syndrome

Acute Coronary SyndromeCoronary Stenting1 more

Comparison of two antiplatelet strategies between months 1 and 12 after coronary stenting for ACS. Efficiency and tolerance évaluation

Unknown status2 enrollment criteria

Registry of Acute Coronary Syndromes in the Lazio Region of Italy

Acute Coronary Syndromes

The NET-SCA Registry has been designed to document and evaluate the clinical epidemiology and current management of Acute Coronary Syndromes in the Lazio Region of Italy.

Unknown status2 enrollment criteria

Prevalence of Metabolic Syndrome in Patients With Schizophrenia in Korea

SchizophreniaMetabolic Syndrome

The aim of this study is to examine the prevalence of the Metabolic syndrome(MetS) in Korean patients with schizophrenia. Primary objective: • To investigate the prevalence of the MetS in Korean patients with schizophrenia Secondary objectives: • To compare the prevalence of the MetS among 3 groups according to antipsychotics: typical antipsychotic monotherapy group, atypical antipsychotic monotherapy group, 2 or more antipsychotics group (polypharmacy)

Unknown status2 enrollment criteria

The Prognostic Assessment of Extubation in Aged Patients With Multiple Organ Dysfunction Syndrome...

Multiple Organ Dysfunction Syndrome

The multiple organ dysfunction syndrome (MODS) has remained the major factor contributing to prolongation of intensive and mortality. It is reported that the mortality rates have varied between 20% and 100%, depending on number, severity, duration, type and combination, and definition of dysfunction. In our study, the investigators explore some comprehensive treatment technology to improved outcomes of MODS patients.

Unknown status4 enrollment criteria

Development of a Blood Test for Marfan Syndrome

Marfan SyndromeMarfan Related Disorders1 more

The objective of this study is to determine whether a simple blood test can be a useful clinical tool for monitoring aortic disease in Marfan syndrome and Marfan-related disorders.

Unknown status6 enrollment criteria

Vascular Ultrasound Versus Intravascular Ultrasound for Diagnosing Iliac Vein Obstruction

Iliac Vein ObstructionMay-Thurner Syndrome1 more

Determine the sensitivity, specificity and accuracy of vascular ultrasound, using direct and indirect ultrasonographic signs, in the obstructive diseases of iliac venous segment, in patients with advanced chronic venous insufficiency (CEAP 3-6), considering the intravascular ultrasound (IVUS) as the gold standard for this diagnosis. Develop an algorithm for noninvasive ultrasound investigation of obstructive lesions in the iliac segment in patients with advanced chronic venous insufficiency (CEAP 3-6).

Unknown status18 enrollment criteria

Exploring Stress and Coping Behaviors of the Major Carer Whose Children With Prader-Willi Syndrome...

Prader-Willi Syndrome

Ask the 4 carers of children with Prader-willi syndrome to disclose their experiences and difficulties for searching better management and intervention

Unknown status3 enrollment criteria

Trends in Intellectual Development in Down Syndrome

Down Syndrome

Previous foreign studies revealed that the IQ in Down syndrome (DS) declines with age, but not any investigation of domestic data in Taiwan was available. Individuals with DS are characterized by limited verbal development, and in this article, authors look into the diverging verbal-nonverbal abilities in the DS phenotype.

Unknown status2 enrollment criteria

Non-invasive Evaluation of Hepatic Fibrosis in Patients With the Metabolic Syndrome

Metabolic Syndrome

Non-alcoholic fatty liver disease (NAFLD) is now recognised as the hepatic complication of the metabolic syndrome of insulin resistance. In some patients, the disease can progress into steatohepatitis (NASH) which associates fatty liver, hepatocellular damage, chronic inflammation and variable and progressive fibrosis. The latter can evolve into cirrhosis and end-stage liver disease. Thus the presence of fibrosis sign the severity of the disease, and therefore its accurate detection is crucial for the identification of patients in need of treatment and appropriate follow-up. To date, histological examination of a biopsy of the liver is the gold standard in the diagnosis of fibrosis. the procedure is however associated with significant complication in 0.01 to 0.1% of cases and with sampling errors because it analyses only a minimal portion fo the liver. The aim of the study is to evaluate, in a population of patients with the metabolic syndrome, whether non-invasive tests may identify those with hepatic fibrosis. At inclusion, serum tests, fibroscan (elastography of the liver by ultra-sounds) and elastography by MRI will be performed. Those tests will be repeated within 2 months. A liver biopsy will be performed if 2 out of the 3 (serum test, fibroscan or elastography) tests are suggestive of hepatic fibrosis. This study will allow to determine whether hepatic fibrosis may be detected by non-invasive means in patients with NAFLD/NASH. whether there is a correlation between non-invase tests and liver biopsy for assessment of fibrosis and it severity whether the presence of fatty liver interfere with the results of the fibroscan and the elastography. whether there are metabolic factors associated with an increased risk of fibrosis in this population.

Unknown status5 enrollment criteria

Molecular Genetic Screening and Identification of Congenital Arrhythmogenic Diseases

Long QT SyndromeHypertrophic Cardiomyopathy1 more

The aim of this study is the identification of familial congenital arrhythmogenic disorders and their clinical follow-up.

Unknown status7 enrollment criteria
1...971972973...976

Need Help? Contact our team!


We'll reach out to this number within 24 hrs